Additionally, within this work, a meta-analysis focusing on a subset of 1221 early relapsing MS cases found that subjects with intrathecal IgM synthesis faced a markedly elevated risk of a subsequent clinical relapse, surpassing the risk associated with OCGBs [42]. Here, CD40LG is linked to myeloid sarcoma.